Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects.
Arii
Shigeki
S
Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. ars.msrg@tmd.ac.jp
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D015398:Signal Transduction / Q000187:drug effects; D057170:Translational Research, Biomedical
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents